We have expressed cDNA encoding the dengue virus structural proteins in Pichia pastoris by chromosomal integration of an expression cassette containing the dengue virus structural genes (CprME). The yeast recombinant E protein migrated during SDS-PAGE as a 65 kDa protein when analysed by Western blotting and radioimmunoprecipitation, which is the expected molecular mass for correctly processed and glycosylated E protein.
We have expressed cDNA encoding the dengue virus structural proteins in Pichia pastoris by chromosomal integration of an expression cassette containing the dengue virus structural genes (CprME). The yeast recombinant E protein migrated during SDS-PAGE as a 65 kDa protein when analysed by Western blotting and radioimmunoprecipitation, which is the expected molecular mass for correctly processed and glycosylated E protein.
Treatment with endoglycosidases showed that the recombinant E protein was modified by the addition of short mannose chains. The E protein migrated with a buoyant density of 1n13 g/cm 3 when analysed using sucrose density gradient centrifugation. Spherical structures with an average diameter of 30 nm, whose morphology resembles dengue virions, were observed in the purified fractions using transmission electron microscopy. Furthermore, the virus-like particles were immunogenic in animals and were able to induce neutralizing antibodies. This is the first report that expression of the structural genes of a flavivirus in yeast is able to generate particulate structures that resemble virions.
The dengue virus genome encodes three structural and seven non-structural proteins and is initially translated as a single polyprotein from which each protein is subsequently released by cellular and virus proteolytic activity (Chambers et al., 1990) . The structural proteins consist of a capsid (C) and two membrane proteins, E and M (or its precursor prM), which are translated in the order CprME at the beginning of the polyprotein. Co-expression of the flaviviral envelope E and prM proteins in a variety of animal cell lines generates viruslike particles (VLPs) which induce neutralizing antibodies Author for correspondence : Richard Sugrue.
Fax j65 779 1117. e-mail mcbsrj!leonis.nus.sg against infectious virus Pincus et al., 1992) . Yeast represents an alternative eukaryotic expression system for the generation of flaviviral glycoproteins and previous studies have demonstrated that Japanese encephalitis virus (JEV) E protein expressed in Saccharomyces cerevisiae can elicit neutralizing antibodies in experimental animals (Fujita et al., 1987) . Yeast as an expression host offers distinct advantages over mammalian expression systems both in terms of scaleability and productivity as well as the proven safety of yeastderived viral proteins for pharmaceutical applications, e.g. hepatitis B vaccine (Cregg et al., 1987) . We have selected the methylotropic yeast Pichia pastoris to express dengue virus structural proteins since several reports have shown that this yeast, unlike S. cerevisiae, is capable of expressing glycoproteins that are both non-hyperglycosylated and lack a terminal 1,3-linked mannose addition (Grinna & Tschopp, 1989 ; Trimble et al., 1991) . Both of these are undesirable modifications that severely limit the potential pharmaceutical applications of recombinant glycoproteins expressed in S. cerevisiae.
We have inserted cDNA encoding the structural genes of dengue virus type 1 (DEN-1) Singapore strain S275\90 (Fu et al., 1992) into the P. pastoris expression vector pHIL-D2 (Invitrogen). Two primers, DIR81E (5h AGCAGAATTCTGATGAACAAC 3h) and DIFYE (5h TTACGAATTCCTATTACGCTTGAACCA 3h), were used to generate a 2n3 kb PCR fragment containing flanking EcoRI restriction sites, using pFA\1 as the template. The template pFA\1 contains the cDNA sequence of the DEN-1 (S275\90) structural genes (CprME, nts 81-2402). Sequencing of the 2n3 kb fragment, by the dideoxy sequencing method, confirmed the sequence of the entire CprME coding region, which is predicted to encode a polypeptide of approximately 100 kDa. This 2n3 kb fragment was ligated to the corresponding EcoRI site in pHIL-D2 to generate pHIL-D2\CprME (Fig. 1 a) . The vectors pHIL-D2 and pHIL-D2\CprME were linearized by NotI digestion and used to transform spheroplasts of the P. pastoris strain GS115. The stable transformants GS115\D2 and GS115\CprME were obtained using pHIL-D2 and pHIL-D2\CprME, respectively, by methods previously described (Cregg et al., 1985) .
The transformants GS115\D2 and GS115\CprME were incubated at 30 mC for 48 h in minimal glycerol medium (Cregg et al., 1987) . The lysate was clarified by centrifugation at 11 000 g for 20 min and analysed by Western blotting using the polyclonal antibody RT951. Molecular masses are in kDa. (c) RIPA of [
35 S]methionine-labelled E protein using RT951 (lanes 1-4) and the monoclonal antibody HAWF1 (lanes 5 and 6). Lane 1, mock-infected C6/36 mosquito cells ; lane 2, DEN-1-infected C6/36 mosquito cells ; lane 3, GS115/D2 ; lane 4, GS115/CprME ; lane 5, GS115/D2 ; and lane 6, GS115/CprME. (d) Western blot analysis of glycosidase-treated recombinant E protein using RT951. The clarified supernatant from GS115/CprME was denatured at 100 mC for 10 min in 0n5 % SDS, 1 % β-mercaptoethanol. Portions of the lysate were made up in either 50 mM sodium phosphate, 1 % NP40, pH 7n5 (lanes 1 and 2) or 50 mM sodium citrate, pH 5n5 (lanes 3 and 4) and incubated at 37 mC for 14 h with or without PNGase F (lanes 1 and 2, respectively) and Endo H (lanes 3 and 4, respectively). Lane 1, mock-treated ; lane 2, 500 U PNGase F (New England Biolabs) ; lane 3, mock-treated ; lane 4, 2000 U Endo H (New England Biolabs). Longer arrows, E protein ; shorter arrow, deglycosylated E protein.
(MGY) (1n3%, w\v, yeast nitrogen base ; 1 % ,v\v, glycerol ; 0n4 µg\ml biotin). Expression from the methanol oxidase promoter was induced by replacing MGY with minimal methanol medium (MM) (1n3%, w\v, yeast nitrogen base ; 0n5% ,v\v, methanol ; 0n4 µg\ml biotin) and continuing the incubation at 30 mC for a further 96 h. Expression of recombinant E protein was detected by Western blot analysis using a rabbit polyclonal antibody (RT951) which recognizes the E protein in DEN-1 (S275\90)-infected cells. Following methanol induction, the immunoblot revealed the presence of a specific 65 kDa antigenic band in GS115\CprME cultures, corresponding to the expected molecular mass for a correctly processed glycosylated E protein (Fig. 1 b) . In contrast, no recombinant DEN-1 E protein was detected in the culture medium despite repeated screening. Additionally, we compared the recombinant E protein expressed in P. pastoris with the E protein in DEN-1-infected mosquito cells by radioimmunoprecipitation (RIPA) using RT951 and a mouse monoclonal antibody raised against the E protein of DEN-1 (HawF1). Analysis of the immunoprecipitates by SDS-PAGE confirmed the identity of the specific radiolabelled 65 kDa species in GS115\CprME (Fig. 1 c) , which migrated identically to the E protein expressed in DEN-1-infected cells. Previous reports using the vaccinia virus expression system suggest that coexpression of the C protein together with prM and E has an inhibitory effect on E protein secretion (Konishi et al., 1991 ; Pincus et al., 1992 ; Fonsaca et al., 1994) , possibly as a result of incomplete processing of the capsid protein. We therefore constructed an additional recombinant vector, pHIL-S1\prME, which uses the yeast pho5 signal sequence rather than the prM virus signal sequence that is present in pHIL-D2\CprME (Chambers et al., 1990) . The E protein expressed by cultures transformed with either pHIL-D2\CprME or pHIL-S1\prME was indistinguishable when analysed by Western blotting and endoglycosidase treatment (R. J. Sugrue, unpublished results), suggesting that co-expression of the capsid protein with the viral envelope proteins has no significant adverse effect on E protein processing in P. pastoris. Analysis of the culture medium by Western blotting indicated that this second transformant did not secrete recombinant E protein into the culture medium.
Although flaviviruses exhibit considerable heterogeneity in the pattern of E protein glycosylation, this produces no significant effect on antigenicity (Winkler et al., 1987 ; Guirakhoo et al., 1989) . In contrast, several reports have suggested that some recombinant viral glycoproteins expressed in P. pastoris, e.g. HIV-1 gp120 (Scorer et al., 1993) , undergo hyperglycosylation, which has the potential to significantly alter both protein antigenicity and immunogenicity. The glycosylation state of the recombinant E protein was therefore analysed using two glycosidases, PNGase F and Endoglycosidase H (Endo H). PNGase F is able to remove the entire carbohydrate moiety from proteins modified by Nlinked glycosylation, whereas Endo H specifically removes high mannose chains. The recombinant E protein was sensitive to treatment with both glycosidases (Fig. 1 d) , indicating that the protein had been modified by the addition of small mannose chains via N-linked glycosylation without the addition of complex sugars. The size difference between the glycosylated and deglycosylated recombinant E protein was approximately 6 kDa, which is consistent with the modification of both potential glycosylation sites in the E protein, further demonstrating the absence of hyperglycosylation. Previous studies have demonstrated that the E protein in mature DEN-1 exhibits a mixed pattern of glycosylation (Fonsaca et al., 1994) , where only one of the N-linked glycans is modified by the addition of complex sugars. Our data suggest that P. pastoris is unable to modify this second glycosylation site, which is presumably a result of the different glyco-transferases present in yeast and animal cells.
We have previously observed that DEN-1 E protein expressed in P. pastoris undergoes extensive proteolytic degradation by an undefined yeast protease activity (R. J. Sugrue, J. L. Fu & Y. C. Chan, unpublished results) . This is similar to earlier reports which showed that expression of the JEV E protein in S. cerevisiae underwent proteolytic degradation (Fujita et al., 1987) . However, we clearly show that coexpression of the E protein with the other DEN-1 structural proteins in P. pastoris is able to protect the E protein from this degradation process. Previous studies have shown that VLPs are generated when the flaviviral structural proteins are coexpressed in animal cell lines (Mason et al., 1991 ; Konishi et al., 1992 ; Pincus et al., 1992) . We wished to determine if similar VLPs were formed in P. pastoris, which could account for the resistance of the E protein to degradation. The yeast-expressed recombinant E protein was therefore analysed using a combination of 5-50 % (w\v) sucrose density gradient centrifugation and transmission electron microscopy. The sucrose gradients were fractionated and the individual fractions assayed for the presence of E protein by Western blot analysis using antibody RT951 (Fig. 2 a) . The immunoblot showed that the peak fraction containing recombinant E protein migrated to a position in the gradient corresponding to a buoyant density of approximately 1n13 g\cm$ (Fig. 2 a, fraction 3) , which is similar to values obtained for flaviviral VLPs expressed in animal cell culture (Schalich et al., 1996) . This peak fraction accounted for 90 % of the antigenic recombinant E protein in the gradient. A faster migrating E protein fraction was also observed (Fig. 2 a, fraction 6) , which appeared to co-migrate with a 50 kDa antigenic protein. This suggests that an association between these two antigenic species may be responsible for the increase in buoyant density. A sample of each fraction was fixed in glutaraldehyde and stained with uranyl acetate prior to analysis by transmission electron microscopy. We observed the presence of spherical particles with uniform morphology (Fig. 2 b) and size distribution (approximately 30 nm) in the peak fraction (Fig. 2 c) . These particulate structures were observed only in gradient fractions showing positive staining for E protein by Western blot analysis and were not detected in cultures transformed with the parent vector, pHIL-D2. Additional studies using monoclonal antibody HAWF1 in immune-electron microscopy confirmed the presence of E protein in the VLPs (R. J. Sugrue, J. L. Fu, J. Howe & Y. C. Chan, unpublished results) . Although the yeastexpressed VLPs were morphologically similar to infectious virus they were significantly smaller than infectious DEN-1 (average diameter 50 nm) (Murphy, 1980) , which may reflect differences in the structural organization between the VLPs and infectious virus.
The failure to detect the DEN-1 E protein in the culture medium suggests that the VLPs expressed in P. pastoris were not secreted. Previous studies have shown that expression of hepatitis B virus envelope proteins in S. cerevisiae produces 20 nm VLPs which accumulate in the cell (Kitano et al., 1987 ; Kobayashi et al., 1988 ; Kuroda et al., 1992) . This inability to secrete the VLPs expressed in yeast is presumably due to the complex nature of the yeast cell wall. It is therefore likely that the size of the DEN-1 VLPs (30 nm) is sufficient to prevent the secretion of VLPs by P. pastoris.
The purified VLPs obtained from the peak fraction were used to immunize two rabbits with six doses of approximately 25 µg per dose. The antiserum from each animal (RT1583 and RT1585) was assayed for the presence of DEN-1 antibodies by using both RIPA and immunofluorescence (IFA) assays. The results obtained with RT1583 are presented in Fig. 3 (a, b) . RT1583 was able to specifically immunoprecipitate a 65 kDa and an 18 kDa protein in detergent extracts prepared from DEN-1-infected cells (Fig. 3 a) . These are the expected sizes for the dengue virus E and prM proteins, respectively. We did not detect the C protein in these cell lysates, suggesting that the immune response is primarily directed against the E and prM proteins. Additional studies using IFA showed that RT1583 was able to recognize dengue virus structural proteins in whole cells infected with DEN-1, producing a strong cytoplasmic staining pattern (Fig. 3 b) . On the basis of our IFA data, we estimated that RT1583 and RT1585 had an antibody titre of 1 : 2560 and 1 : 625, respectively. We employed the plaquereduction assay, using the DEN-1\S275\90 stain (25 p.f.u. per well), to estimate the level of neutralizing antibodies present in RT1583. We estimated that RT1583 had a neutralization titre of 1 : 10, which compares with a neutralization titre of 1 : 5 for RT1585 and 1 : 40 for the control serum, RT951. These data collectively demonstrate the immunogenicity of the VLPs and show that they are able to induce virusneutralizing activity.
In conclusion, we report here that expression of the DEN-1 structural genes (CprME) in P. pastoris leads to the generation of particulate structures that contain E protein and resemble dengue virions. The recombinant E protein is processed in an identical manner to that in virus-infected cells and is further modified by the addition of short mannose chains via N-linked glycosylation. These VLPs show immunogenicity and are able to elicit neutralizing antibodies. This expression system therefore offers an alternative method for generating particulate dengue virus E protein. We are currently using this system to express other constructs containing DEN-1 structural proteins.
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